Online learning for today’s arthritis patient
Lesson 3 – Treatment Options and Shared Decision-making
In Lessons 1 and 2, we explored what lupus is, how it affects the body, and how doctors or specialists diagnose and monitor the disease. Once lupus has been diagnosed, the next step is developing a treatment plan that reflects your symptoms, disease activity, lifestyle, and personal goals.
Lupus treatment has improved significantly over the past two decades. Earlier diagnosis, better monitoring, and new treatment options are helping many people achieve improved disease control and quality of life. While there is currently no cure for lupus, effective treatment can help reduce inflammation, control symptoms, prevent flares, protect organs from damage, and help people maintain their daily activities and long-term health.
Treatment decisions can sometimes feel overwhelming. Understanding the goals of treatment, how medications work, and what questions to ask can help you become a more informed and confident partner in your care.
Please note that there are several forms of lupus, but the most common and serious form is systemic lupus erythematosus (SLE). When people use the term “lupus”, they are usually referring to SLE. This Course focuses primarily on SLE, which is most often associated with arthritis, flares, and involvement of organs such as the kidneys, heart, lungs, and brain.
Treatment goals in lupus
The primary goals of lupus treatment are to:
- Reduce inflammation and disease activity
- Control symptoms such as pain, fatigue, rashes, and joint swelling
- Prevent flares
- Protect organs from damage
- Reduce medication-related side effects
- Maintain physical function and quality of life
- Support long-term health and wellbeing
Treatment plans vary because lupus affects each person differently. Modern lupus care increasingly focuses on achieving low disease activity or remission whenever possible while minimizing treatment-related risks. Disease activity refers to how active lupus is in your body at a given time. Remission means lupus is quiet and causing few or no symptoms.
Understanding lupus medications
Lupus treatment is about more than controlling symptoms. The goal is also to prevent long-term damage to organs such as the kidneys, heart, lungs, and brain.
Long-term disease control
Hydroxychloroquine is considered a cornerstone treatment for most people living with systemic lupus erythematosus (SLE). Originally developed to treat malaria, hydroxychloroquine helps regulate the immune system and reduce inflammation.
Research has shown that hydroxychloroquine can:
- Reduce disease activity
- Lower the risk of flares
- Help protect organs from damage
- Improve long-term outcomes
- Reduce the need for corticosteroids
Because of these benefits, lupus experts generally recommend hydroxychloroquine for most patients unless there is a specific reason it cannot be used.
Regular eye examinations are important because rare retinal side effects can occur with long-term use. Your health care provider will recommend appropriate eye monitoring.
Inflammation reduction during flares
Corticosteroids such as prednisone are powerful anti-inflammatory medications.
They can be highly effective at controlling inflammation and managing flares quickly. However, long-term steroid use may increase the risk of:
- Weight gain
- Osteoporosis
- Diabetes
- High blood pressure
- Cataracts
- Increased infection risk
- Mood changes
Current lupus treatment guidelines emphasize using the lowest effective steroid dose for the shortest possible time.
Many newer treatment strategies focus on reducing dependence on long-term corticosteroid therapy whenever possible.
Remember
Corticosteroids can be very effective, especially during flares. Because long-term use may cause side effects, health care providers try to use the lowest effective dose for the shortest possible time. Controlling moderate to severe lupus
Some people require immunosuppressive medications that suppress immune system activity more directly. These medications may be used when lupus affects major organs such as the kidneys, or when disease activity is not adequately controlled with other therapies.
Examples include:
- Azathioprine
- Methotrexate
- Mycophenolate mofetil
- Cyclophosphamide
These medications can be very effective, but they also require regular monitoring because they may affect blood counts, liver function, or infection risk.
Your doctor or specialist will explain the benefits and risks of each medication and the monitoring that is required.
Newer targeted therapies
In recent years, advances in lupus research have led to the development of targeted biologic therapies. Biologic medications are newer treatments designed to target specific parts of the immune system involved in lupus.
Examples include:
- Belimumab
- Anifrolumab
These therapies may be considered when disease activity remains uncontrolled despite standard treatments or when steroid-sparing approaches are needed.
Not everyone with lupus requires biologic therapy. However, these treatments represent important progress and provide additional options for patients whose disease remains active despite conventional treatment.
Researchers continue to investigate new therapies that may further improve outcomes and reduce treatment-related side effects.
Access to medications and reimbursement
Advances in lupus treatment have improved outcomes for many people. But receiving a prescription is only one step in accessing treatment. Patients must also be able to obtain the medication, afford it, and maintain access over time.
In Canada, medication coverage varies depending on where a person lives, the type of insurance they have, and the medication prescribed. Some medications are covered through public drug plans, some through private insurance plans, and others may require special authorization before reimbursement is approved.
For people living with lupus, uncertainty about medication coverage can be stressful. Delays in reimbursement decisions, out-of-pocket costs, and changing insurance requirements can create additional challenges when managing a chronic disease.
When access barriers occur, patients may benefit from speaking with their healthcare team, patient support programs, pharmacists, or insurance providers to better understand available options and resources.
Medication safety and monitoring
Every medication has potential benefits and risks. Health care providers carefully balance these considerations when recommending treatment.
Important aspects of medication safety include:
- Attending regular appointments
- Completing recommended blood and urine testing
- Reporting side effects promptly
- Discussing vaccinations
- Informing health care providers about other medications and supplements
- Following recommended monitoring schedules
Never stop or change a medication without first discussing it with your healthcare team.
If you have concerns about side effects, effectiveness, or safety, bring those concerns forward. Many treatment challenges can be addressed through open communication.
Staying on track with your medications
Medication adherence means staying on track and taking medications as prescribed. This can be challenging when symptoms improve, medications cause side effects, or treatment routines become complicated. But stopping medications without medical guidance may increase the risk of disease flares and long-term complications. If you are having difficulty taking your medications, speak with your healthcare team rather than stopping them on your own.
Strategies that may help include:
- Using pill organizers
- Setting reminders
- Linking medications to daily routines
- Asking questions about treatment goals
- Discussing side effects early
- Understanding how each medication contributes to disease control
Knowing why a medication has been prescribed often makes it easier to remain engaged with treatment over time.
Shared decision-making
Shared decision-making means patients and health care providers work together when making treatment decisions. Shared decision-making recognizes that you are the expert on how lupus affects your daily life, while your healthcare team brings expertise about diagnosis and treatment. Working together leads to better decisions.
Rather than simply being told what to do, patients are encouraged to:
- Ask questions
- Share concerns
- Discuss personal goals
- Consider treatment benefits and risks
- Express preferences and values
Shared decision-making recognizes that patients are experts in their own experiences and that treatment decisions should reflect both medical evidence and individual priorities.
Questions for your doctor or specialist:
- What is this medication intended to do? Why is it recommended for me?
- What side effects should I watch for?
- How will we know if treatment is working? What benefits should I expect?
- Are there alternative options?
- What monitoring is required?
- How long will it take before this medication starts working?
- What are the risks of not treating my lupus?
- What happens if this medication doesn’t work?
- Are there lifestyle changes that can help alongside my medications?
These conversations can help build trust, improve understanding, and support treatment decisions that align with your goals and values.
Learn from an Expert
References
- Arthritis Consumer Experts. Medication Treatments.
- Arthritis Consumer Experts. National Survey on Lupus in Canada, Part 1.
- American College of Rheumatology. 2025 Guideline for the Treatment of Systemic Lupus Erythematosus.
- Fanouriakis A, et al. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Annals of the Rheumatic Diseases. 2024.
- Lupus Foundation of America. Treating Lupus: A Guide.
- Lupus treatment and disease management resources.